Literature DB >> 20530807

Non-atheromatous arterial stenoses in atypical haemolytic uraemic syndrome associated with complement dysregulation.

Chantal Loirat1, Marie-Alice Macher, Monique Elmaleh-Berges, Theresa Kwon, Georges Deschênes, Timothy H J Goodship, Charles Majoie, Jean-Claude Davin, Raphael Blanc, Julien Savatovsky, Jacques Moret, Véronique Fremeaux-Bacchi.   

Abstract

BACKGROUND: A child, who presented atypical haemolytic uraemic syndrome (aHUS) at the age of 1 month, developed cerebral ischaemic events at the age of 10 years.
RESULTS: Stenoses of both carotid arteries, left subclavian and vertebral arteries, several intracranial, right humeral, several coronary, and all pulmonary arteries were demonstrated. At the age of 13 years, left subclavian and right cervical carotid arteries were occluded. Right carotid recanalization induced intracranial dissection and death. The child had a Lys350Asp factor B mutation.
CONCLUSION: Arterial steno-occlusive lesions appear as potential complications of dysregulated complement activation in aHUS. Endovascular treatment should be considered cautiously in this setting.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20530807     DOI: 10.1093/ndt/gfq319

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  15 in total

Review 1.  Cardiovascular complications in atypical haemolytic uraemic syndrome.

Authors:  Marina Noris; Giuseppe Remuzzi
Journal:  Nat Rev Nephrol       Date:  2014-01-14       Impact factor: 28.314

2.  Macrovascular involvement in a child with atypical hemolytic uremic syndrome.

Authors:  Karolis Ažukaitis; Chantal Loirat; Michal Malina; Irina Adomaitienė; Augustina Jankauskienė
Journal:  Pediatr Nephrol       Date:  2013-12-19       Impact factor: 3.714

Review 3.  Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies.

Authors:  Julien Zuber; Fadi Fakhouri; Lubka T Roumenina; Chantal Loirat; Véronique Frémeaux-Bacchi
Journal:  Nat Rev Nephrol       Date:  2012-10-02       Impact factor: 28.314

Review 4.  An international consensus approach to the management of atypical hemolytic uremic syndrome in children.

Authors:  Chantal Loirat; Fadi Fakhouri; Gema Ariceta; Nesrin Besbas; Martin Bitzan; Anna Bjerre; Rosanna Coppo; Francesco Emma; Sally Johnson; Diana Karpman; Daniel Landau; Craig B Langman; Anne-Laure Lapeyraque; Christoph Licht; Carla Nester; Carmine Pecoraro; Magdalena Riedl; Nicole C A J van de Kar; Johan Van de Walle; Marina Vivarelli; Véronique Frémeaux-Bacchi
Journal:  Pediatr Nephrol       Date:  2015-04-11       Impact factor: 3.714

Review 5.  Hemolytic uremic syndrome.

Authors:  Caterina Mele; Giuseppe Remuzzi; Marina Noris
Journal:  Semin Immunopathol       Date:  2014-02-14       Impact factor: 9.623

Review 6.  Advances and challenges in the management of complement-mediated thrombotic microangiopathies.

Authors:  Jean-Claude Davin; Nicole C A J van de Kar
Journal:  Ther Adv Hematol       Date:  2015-08

Review 7.  Extra-renal manifestations of atypical hemolytic uremic syndrome.

Authors:  Cassandra Formeck; Agnieszka Swiatecka-Urban
Journal:  Pediatr Nephrol       Date:  2018-08-14       Impact factor: 3.714

Review 8.  Atypical hemolytic uremic syndrome.

Authors:  Chantal Loirat; Véronique Frémeaux-Bacchi
Journal:  Orphanet J Rare Dis       Date:  2011-09-08       Impact factor: 4.123

Review 9.  Complement therapy in atypical haemolytic uraemic syndrome (aHUS).

Authors:  Edwin K S Wong; Tim H J Goodship; David Kavanagh
Journal:  Mol Immunol       Date:  2013-06-28       Impact factor: 4.174

10.  Subclinical inflammatory status in Rett syndrome.

Authors:  Alessio Cortelazzo; Claudio De Felice; Roberto Guerranti; Cinzia Signorini; Silvia Leoncini; Alessandra Pecorelli; Gloria Zollo; Claudia Landi; Giuseppe Valacchi; Lucia Ciccoli; Luca Bini; Joussef Hayek
Journal:  Mediators Inflamm       Date:  2014-01-06       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.